Log in to save to my catalogue

Clinical Application of Ultraviolet C Inactivation of Severe Acute Respiratory Syndrome Coronavirus...

Clinical Application of Ultraviolet C Inactivation of Severe Acute Respiratory Syndrome Coronavirus...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dfd7787a1eaf487db2bd034760a9ebd6

Clinical Application of Ultraviolet C Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 in Contaminated Hospital Environments

About this item

Full title

Clinical Application of Ultraviolet C Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 in Contaminated Hospital Environments

Publisher

Switzerland: MDPI AG

Journal title

Viruses, 2021-11, Vol.13 (12), p.2367

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

To overcome the ongoing coronavirus disease 2019 (COVID-19) pandemic, transmission routes, such as healthcare worker infection, must be effectively prevented. Ultraviolet C (UVC) (254 nm) has recently been demonstrated to prevent environmental contamination by infected patients; however, studies on its application in contaminated hospital settings...

Alternative Titles

Full title

Clinical Application of Ultraviolet C Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 in Contaminated Hospital Environments

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dfd7787a1eaf487db2bd034760a9ebd6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dfd7787a1eaf487db2bd034760a9ebd6

Other Identifiers

ISSN

1999-4915

E-ISSN

1999-4915

DOI

10.3390/v13122367

How to access this item